Evidence map›Paper›PMID 40282854›Full record

ArticleMedicina (Kaunas, Lithuania)2025

Incidence and Prognostic Significance of Hormonal Receptors and HER2 Status Conversion in Recurrent Breast Cancer: A Retrospective Study in a Single Institute.

Einas M Yousef, Abdullah Mansour Alswilem, Zahrah S Alfaraj, Danya J Alhamood, Ghfran K Ghashi, Hanan S Alruwaily, Shouq S Al Yahya, Eyad Alsaeed

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Einas M YousefCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.ORCID 0000-0002-8935-0183
Abdullah Mansour AlswilemOncology Center, King Saud University Medical City, Riyadh 19910, Saudi Arabia.ORCID 0009-0003-0193-776X
Zahrah S AlfarajCollege of Medicine, Dar Aluloom University, Riyadh 13314, Saudi Arabia.
Danya J AlhamoodCollege of Medicine, Dar Aluloom University, Riyadh 13314, Saudi Arabia.
Ghfran K GhashiCollege of Medicine, Dar Aluloom University, Riyadh 13314, Saudi Arabia.
Hanan S AlruwailyCollege of Medicine, Dar Aluloom University, Riyadh 13314, Saudi Arabia.
Shouq S Al YahyaCollege of Medicine, Dar Aluloom University, Riyadh 13314, Saudi Arabia.
Eyad AlsaeedDepartment of Radiation Oncology, College of Medicine, King Saud University, Riyadh 11411, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesNeoplasm Recurrence, LocalReceptors, EstrogenReceptors, ProgesteroneAdultAgedBiomarkers, TumorCohort StudiesFemaleHumansIncidenceMiddle AgedPrognosisRetrospective StudiesSaudi ArabiaBiomarkers, TumorERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, Progesteronebreast cancerestrogen receptorHER2 statusprogesterone receptorprognostic significancereceptor conversionsurvival analysis

Identifiers

PMID40282854
PMCPMC12028628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.